Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kaposi's sarcoma: an update.

Robert A Schwartz1

  • 1Dermatology, New Jersey Medical School, Newark, New Jersey 07103, USA. roschwar@umdnj.edu

Journal of Surgical Oncology
|August 31, 2004
PubMed
Summary

Kaposi's sarcoma (KS) remains a challenge, with human herpesvirus 8 (HHV-8) as a key factor. Anti-herpes therapy shows promise for preventing KS in at-risk populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polypoid Acral Amelanotic Melanoma: A Rare Variant Treated with Wide and Deep Surgical Excision.

Acta dermatovenerologica Croatica : ADC·2026
Same author

Alopecia areata: current concepts.

Wiener klinische Wochenschrift·2026
Same author

Acral acanthotic anomaly: a comprehensive review.

Italian journal of dermatology and venereology·2026
Same author

Vincent A. Cipollaro MD (1931-2025): A Foundational Pillar in International Dermatology.

International journal of dermatology·2026
Same author

Cutaneous Amyloidosis: An Updated Approach Focusing on Macular Amyloidosis.

Dermatology (Basel, Switzerland)·2026
Same author

Keratin-TMAO dressing accelerates full-thickness skin wound healing in diabetic rats via M2-macrophage polarization and the activation of PI3K/AKT/mTOR signaling pathway.

International journal of biological macromolecules·2025

Area of Science:

  • Oncology
  • Virology
  • Dermatology

Background:

  • Kaposi's sarcoma (KS) presents diagnostic and etiological challenges.
  • KS was a common presenting sign in early Acquired Immunodeficiency Syndrome (AIDS) cases.
  • Highly active anti-retroviral therapy (HAART) has reduced KS incidence in AIDS patients.

Purpose of the Study:

  • To review advances in Kaposi's sarcoma understanding.
  • To highlight the etiological role of human herpesvirus 8 (HHV-8).
  • To discuss diagnostic considerations and therapeutic options for KS.

Main Methods:

  • Review of existing literature on Kaposi's sarcoma.
  • Analysis of the association between HHV-8 and KS.
  • Evaluation of diagnostic challenges and differential diagnoses.
  • Assessment of current and potential therapeutic strategies.

Main Results:

  • Human herpesvirus 8 (HHV-8) is necessary but not sufficient for KS development.
  • KS prevalence varies geographically and is linked to HHV-8 seroprevalence.
  • Anti-herpes therapy may reduce KS risk in susceptible individuals.
  • Differential diagnosis of KS requires awareness of clinical variants and other conditions.

Conclusions:

  • Effective management of KS requires understanding its complex etiology and clinical presentations.
  • Targeting HHV-8 with anti-herpes therapies offers a potential preventive strategy for high-risk groups.
  • Avoiding immunosuppression is crucial when managing KS, especially in the context of HIV/AIDS.

Related Experiment Videos